- Home
- LPA vs SMTI Comparison
LPA vs SMTI Comparison
Compare LPA & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPA
- SMTI
- Stock Information
- Founded
- LPA 2013
- SMTI 1982
- Country
- LPA United States
- SMTI United States
- Employees
- LPA N/A
- SMTI N/A
- Industry
- LPA
- SMTI Medical/Dental Instruments
- Sector
- LPA
- SMTI Health Care
- Exchange
- LPA Nasdaq
- SMTI Nasdaq
- Market Cap
- LPA 241.7M
- SMTI 288.2M
- IPO Year
- LPA N/A
- SMTI N/A
- Fundamental
- Price
- LPA $6.20
- SMTI $37.32
- Analyst Decision
- LPA
- SMTI Buy
- Analyst Count
- LPA 0
- SMTI 1
- Target Price
- LPA N/A
- SMTI $44.00
- AVG Volume (30 Days)
- LPA 38.6K
- SMTI 31.9K
- Earning Date
- LPA 11-13-2024
- SMTI 11-12-2024
- Dividend Yield
- LPA N/A
- SMTI N/A
- EPS Growth
- LPA N/A
- SMTI N/A
- EPS
- LPA N/A
- SMTI N/A
- Revenue
- LPA $42,725,424.00
- SMTI $78,056,873.00
- Revenue This Year
- LPA N/A
- SMTI $26.97
- Revenue Next Year
- LPA N/A
- SMTI $18.91
- P/E Ratio
- LPA N/A
- SMTI N/A
- Revenue Growth
- LPA 13.12
- SMTI 24.66
- 52 Week Low
- LPA $6.00
- SMTI $26.00
- 52 Week High
- LPA $525.00
- SMTI $43.25
- Technical
- Relative Strength Index (RSI)
- LPA N/A
- SMTI 62.92
- Support Level
- LPA N/A
- SMTI $33.50
- Resistance Level
- LPA N/A
- SMTI $38.22
- Average True Range (ATR)
- LPA 0.00
- SMTI 2.04
- MACD
- LPA 0.00
- SMTI 0.22
- Stochastic Oscillator
- LPA 0.00
- SMTI 72.59
About LPA Logistic Properties of the Americas
Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns and manages a diversified portfolio of warehouse logistics assets in Central America and the South America. It focuses on modern Class A logistics real estate in high growth and high barrier-to-entry markets that are undersupplied and have low penetration rates.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.